Jewish Hospital

According to SRTR data from November 2025, Jewish Hospital reports a 1-year graft survival rate of 87.5% for kidney-pancreas transplants, compared to a national average of 94.9%. The 3-year survival rate is 90.0%. Survival rates are risk-adjusted estimates and may not predict individual outcomes.

Jewish Hospital performed approximately 19 kidney-pancreas transplants during the most recent SRTR reporting period. Higher transplant volume is often associated with greater center experience, though volume alone does not determine outcomes. The OPTN recommends considering multiple factors when evaluating a transplant center.

According to the latest SRTR data, approximately 14 patients are on the kidney-pancreas transplant waiting list at Jewish Hospital. Wait times depend on factors including blood type, medical urgency, body size, geographic region, and organ allocation policies set by OPTN/UNOS. Your transplant team can provide a personalized estimate.

Jewish Hospital ranks #98 out of 112 reporting kidney-pancreas transplant centers nationally by 1-year graft survival rate. The center's rate is 7.4 percentage points below the national average. Rankings are based on SRTR risk-adjusted estimates and exclude centers with insufficient case volume for statistical reliability.

Beyond survival statistics, important factors include the center's experience with kidney-pancreas transplants, geographic proximity (which affects organ allocation timing through OPTN distribution policies), your insurance network, the multidisciplinary team's expertise, post-transplant follow-up logistics, and the availability of living donor programs if applicable. Discuss all options with your referring physician and the transplant team at Jewish Hospital.